Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting the complement system.

J E Marsh1, J R Pratt, S H Sacks

  • 1Department of Nephrology and Transplantation, Guy's Hospital, King's College, University of London, UK.

Current Opinion in Nephrology and Hypertension
|December 14, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultralow Loss Torsion Micropendula for Chipscale Gravimetry.

Physical review letters·2025
Same author

Bridging classical and quantum mechanics.

Metrologia·2020
Same author

Thrombalexins: Cell-Localized Inhibition of Thrombin and Its Effects in a Model of High-Risk Renal Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Invited Article: A precise instrument to determine the Planck constant, and the future kilogram.

The Review of scientific instruments·2016
Same author

Complement-here, there and everywhere, but what about the transplanted organ?

Seminars in immunology·2016
Same author

Registered Replication Report: Schooler and Engstler-Schooler (1990).

Perspectives on psychological science : a journal of the Association for Psychological Science·2015
Same journal

Sex differences in renal acid-base regulation.

Current opinion in nephrology and hypertension·2026
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
Same journal

Social determinants of chronic kidney disease: from association to clinical and population action.

Current opinion in nephrology and hypertension·2026
See all related articles

New complement inhibitors offer targeted therapies for various diseases. These advanced treatments aim to reduce tissue damage in conditions like organ transplantation and cancer, overcoming limitations of earlier methods.

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • The complement cascade is crucial in immune responses and disease pathogenesis.
  • Early complement inhibitors faced limitations in therapeutic efficacy due to bioavailability and antigenicity.
  • Advances in understanding complement biology have spurred the development of novel inhibitors.

Purpose of the Study:

  • To review recent evidence on the therapeutic potential of complement inhibitors.
  • To highlight advancements in complement inhibitor development.
  • To explore the role of complement inhibition in reducing tissue damage.

Main Methods:

  • Review of recent scientific literature on complement inhibitors.
  • Analysis of data from experimental models and clinical studies.
  • Examination of naturally occurring and synthetic complement inhibitors.

Related Experiment Videos

Main Results:

  • First-generation inhibitors provided research tools but had limited human therapeutic application.
  • Modern humanized antibodies and synthetic molecules show improved therapeutic potential.
  • Targeted inhibition strategies offer effective treatment with fewer side effects.

Conclusions:

  • Complement inhibitors represent a promising therapeutic strategy for various conditions.
  • Precision inhibition of the complement cascade can mitigate tissue damage effectively.
  • Further research into complement inhibition is warranted for diverse clinical applications.